RecruitingNot Applicable

The Effects of an Acute Dose of a Betalain-rich Concentrate on Repeated-sprint Cycling Performance and Recovery.

United States10 participantsStarted 2024-03-06

Plain-language summary

Betalains have well-known antioxidant and anti-inflammatory properties. Recent investigations examining the effects of a betalain-rich concentrate (BRC) on exercise and recovery performance show promise of BRC as an ergogenic aid. To date, no study has examined the effects of a single dose of a BRC on supramaximal performance and recovery. Therefore, the purpose of this study is to examine the effects of an acute dose of BRC on repeated-sprint cycling performance and recovery.

Who can participate

Age range18 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy, recreationally active males and females * Aged 18-40 * Free of disease or injury Exclusion Criteria: * Have any musculoskeletal injuries that could be made worse by participating in this study (e.g., sprain or strain of lower limb) * Have documented medical conditions (i.e., hypertension, asthma, heart disease, diabetes) or exhibit signs and symptoms of medical conditions * Taking any medication that would interfere with the interpretation of our results. These include, but are not limited to, anti-inflammatory drugs, antibiotics, anti-hypertensives, and any medicine controlling the digestive system.

What they're measuring

Repeated Sprint Performance

Timeframe: Each data point will be assessed immediately after each Wingate sprint

Repeated Sprint Performance

Timeframe: Each data point will be assessed immediately after each Wingate sprint

Trial details

NCT IDNCT06274385

SponsorDrexel University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06

View on ClinicalTrials.gov More Nutraceuticals trials